AMZN,Jeff Bezos' rocket company test-flies suborbital spaceship CAPE CANAVERAL, Fla., April 30 Blue Origin, a startup space company owned by Amazon.com chief Jeff Bezos, launched an experimental suborbital spaceship from Texas, the first in a series of test flights to develop commercial unmanned and passenger spaceflight services, the company said on Thursday. 
AXP,U.S. judge issues injunction against American Express in antitrust suitUPDATE 1-American Express told it cannot enforce anti-steering rules against merchantsAmerican Express told it cannot enforce anti-steering rules against merchants NEW YORK Merchants unhappy with the fees American Express Co  charges them may steer customers toward less expensive cards without fearing retaliation from the credit card company, a federal judge ruled on Thursday.  American Express told it cannot enforce anti-steering rules against merchants NEW YORK Merchants unhappy with the fees American Express Co  charges them may steer customers toward less expensive cards without fearing retaliation from the credit card company, a federal judge ruled on Thursday. NEW YORK, April 30 Merchants unhappy with the fees American Express Co  charges them may steer customers toward less expensive cards without fearing retaliation from the credit card company, a federal judge ruled on Thursday.American Express told it cannot enforce anti-steering rules against merchants NEW YORK Merchants unhappy with the fees American Express Co  charges them may steer customers toward less expensive cards without fearing retaliation from the credit card company, a federal judge ruled on Thursday.   UPDATE 1-American Express told it cannot enforce anti-steering rules against merchantsAmerican Express told it cannot enforce anti-steering rules against merchants NEW YORK Merchants unhappy with the fees American Express Co  charges them may steer customers toward less expensive cards without fearing retaliation from the credit card company, a federal judge ruled on Thursday.  American Express told it cannot enforce anti-steering rules against merchants NEW YORK Merchants unhappy with the fees American Express Co  charges them may steer customers toward less expensive cards without fearing retaliation from the credit card company, a federal judge ruled on Thursday. NEW YORK, April 30 Merchants unhappy with the fees American Express Co  charges them may steer customers toward less expensive cards without fearing retaliation from the credit card company, a federal judge ruled on Thursday.American Express told it cannot enforce anti-steering rules against merchants NEW YORK Merchants unhappy with the fees American Express Co  charges them may steer customers toward less expensive cards without fearing retaliation from the credit card company, a federal judge ruled on Thursday.  NEW YORK, April 30 A federal judge said in a written ruling on Thursday he had granted much of the U.S. Justice Department's demands for an antitrust injunction against American Express Co in a lawsuit over steering rules for merchants.UPDATE 1-American Express told it cannot enforce anti-steering rules against merchantsAmerican Express told it cannot enforce anti-steering rules against merchants NEW YORK Merchants unhappy with the fees American Express Co  charges them may steer customers toward less expensive cards without fearing retaliation from the credit card company, a federal judge ruled on Thursday.  American Express told it cannot enforce anti-steering rules against merchants NEW YORK Merchants unhappy with the fees American Express Co  charges them may steer customers toward less expensive cards without fearing retaliation from the credit card company, a federal judge ruled on Thursday. NEW YORK, April 30 Merchants unhappy with the fees American Express Co  charges them may steer customers toward less expensive cards without fearing retaliation from the credit card company, a federal judge ruled on Thursday.American Express told it cannot enforce anti-steering rules against merchants NEW YORK Merchants unhappy with the fees American Express Co  charges them may steer customers toward less expensive cards without fearing retaliation from the credit card company, a federal judge ruled on Thursday.   
AIG,AIG first quarter earnings down slightly on interest rates, returnsAIG first quarter earnings down slightly on interest rates, returns NEW YORK American International Group Inc's  first-quarter earnings fell slightly as low interest rates and weaker returns from alternative investments offset improvements in its commercial insurance business.  AIG first quarter earnings down slightly on interest rates, returns NEW YORK American International Group Inc's  first-quarter earnings fell slightly as low interest rates and weaker returns from alternative investments offset improvements in its commercial insurance business. NEW YORK, April 30 American International Group Inc's first-quarter earnings fell slightly as low interest rates and weaker returns from alternative investments offset improvements in its commercial insurance business.AIG first quarter earnings down slightly on interest rates, returns NEW YORK American International Group Inc's  first-quarter earnings fell slightly as low interest rates and weaker returns from alternative investments offset improvements in its commercial insurance business.  
AAPL,US STOCKS-Wall St falls on mixed economic data; Apple weighsUPDATE 2-Distressed audio-chip maker Audience sells itself to KnowlesUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.       US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.        US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.       US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.       * Deal to add to earnings in Q4 of 2016   (Adds analyst comment, details; Updates share)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.       US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.         UPDATE 2-Distressed audio-chip maker Audience sells itself to KnowlesUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.       US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.        US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.       US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.       * Deal to add to earnings in Q4 of 2016   (Adds analyst comment, details; Updates share)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.       US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.        * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)UPDATE 2-Distressed audio-chip maker Audience sells itself to KnowlesUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.       US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.        US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.       US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.       * Deal to add to earnings in Q4 of 2016   (Adds analyst comment, details; Updates share)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.       US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayUS STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.      US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)US STOCKS SNAPSHOT-Wall St ends down as Apple, biotechs weighUS STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.     US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    April 30 U.S. stocks sold off on Thursday, pushing the Nasdaq down for a fourth day, as Apple shares declined and earnings results in other tech and biotech names disappointed.US STOCKS-Wall St drops with tech shares; indexes up for monthUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.    US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)US STOCKS-Wall St drops with tech shares; LinkedIn falls lateStock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.   Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)Stock market hammered despite upbeat dataCORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.  CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study. U.S. stocks, led by the Nasdaq, sold off on Thursday as Apple shares declined, and tech and biotech quarterly results disappointed.CORRECTED-OFFICIAL-Apple Watch has lowest hardware cost to price - IHS April 30 Apple Inc's Watch has the lowest ratio of hardware costs to retail price across any Apple phone, according to a preliminary estimate by research firm IHS after a teardown study.         
BA,U.S. FAA proposes fix for possible power loss issue in Boeing's 787 April 30 The U.S. Federal Aviation Administration said it would ask the operators of Boeing Co's  model 787 airplanes to deactivate the plane's electrical power system periodically. 
BWA,Auto supplier BorgWarner revenue falls 4.8 pct April 30 Automotive supplier BorgWarner Inc  reported a 4.8 percent fall in quarterly revenue as a stronger dollar reduced the value of overseas sales. 
BMY,DIARY-U.S. MEETINGS/WEEK AHEADBayer says Xarelto isn't losing U.S. market share to Eliquis FRANKFURT, April 30 Bayer brushed off concern that its stroke prevention pill Xarelto may be losing market share to rival Bristol-Myers Squibb's Eliquis in the United States.  Bayer says Xarelto isn't losing U.S. market share to Eliquis FRANKFURT, April 30 Bayer brushed off concern that its stroke prevention pill Xarelto may be losing market share to rival Bristol-Myers Squibb's Eliquis in the United States. Thomson Reuters April 30, 2015 - Corporate Meetings for US companies for Week ahead.         S&P; 500 Earnings - MONTH AHEAD     Dividends                            Non S&P; 500 - Weekly             Federal Reserve events               ConferenceCall/Webcast - Weekly  Meetings - Weekly                                Xtra users can see more details on conference calls & webcasts by hovering your mouse  over the RIC, right click, no click on Related Co Data, now click on Co Events.                 Bayer says Xarelto isn't losing U.S. market share to Eliquis FRANKFURT, April 30 Bayer brushed off concern that its stroke prevention pill Xarelto may be losing market share to rival Bristol-Myers Squibb's Eliquis in the United States.  
CELG,BRIEF-Celgene sees 2015 Revlimid sales at or above high end of forecast rangeUS STOCKS-Wall St opens lower as Apple, Celgene weighCelgene revenue rises less than expected due to strong dollarUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)       US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      U.S. biotechnology company Celgene Corp  posted a lower-than-expected quarterly revenue, hit by a stronger dollar, but said the dollar would not hurt full-year sales and profit more that it had already forecast.US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)        Celgene revenue rises less than expected due to strong dollarUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)       US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      U.S. biotechnology company Celgene Corp  posted a lower-than-expected quarterly revenue, hit by a stronger dollar, but said the dollar would not hurt full-year sales and profit more that it had already forecast.US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)       * Indexes down: Dow 0.7 pct, S&P; 0.7 pct, Nasdaq 1 pct   (Updates to open)Celgene revenue rises less than expected due to strong dollarUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)       US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      U.S. biotechnology company Celgene Corp  posted a lower-than-expected quarterly revenue, hit by a stronger dollar, but said the dollar would not hurt full-year sales and profit more that it had already forecast.US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)         US STOCKS-Wall St opens lower as Apple, Celgene weighCelgene revenue rises less than expected due to strong dollarUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)       US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      U.S. biotechnology company Celgene Corp  posted a lower-than-expected quarterly revenue, hit by a stronger dollar, but said the dollar would not hurt full-year sales and profit more that it had already forecast.US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)        Celgene revenue rises less than expected due to strong dollarUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)       US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      U.S. biotechnology company Celgene Corp  posted a lower-than-expected quarterly revenue, hit by a stronger dollar, but said the dollar would not hurt full-year sales and profit more that it had already forecast.US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)       * Indexes down: Dow 0.7 pct, S&P; 0.7 pct, Nasdaq 1 pct   (Updates to open)Celgene revenue rises less than expected due to strong dollarUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)       US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      U.S. biotechnology company Celgene Corp  posted a lower-than-expected quarterly revenue, hit by a stronger dollar, but said the dollar would not hurt full-year sales and profit more that it had already forecast.US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)        * Says now expects 2015 Revlimid sales at or above upper end of forecast range of $5.6 billion to $5.7 billion  Further company coverage:    (Reporting By Bill Berkrot)US STOCKS-Wall St opens lower as Apple, Celgene weighCelgene revenue rises less than expected due to strong dollarUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)       US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      U.S. biotechnology company Celgene Corp  posted a lower-than-expected quarterly revenue, hit by a stronger dollar, but said the dollar would not hurt full-year sales and profit more that it had already forecast.US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)        Celgene revenue rises less than expected due to strong dollarUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)       US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      U.S. biotechnology company Celgene Corp  posted a lower-than-expected quarterly revenue, hit by a stronger dollar, but said the dollar would not hurt full-year sales and profit more that it had already forecast.US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)       * Indexes down: Dow 0.7 pct, S&P; 0.7 pct, Nasdaq 1 pct   (Updates to open)Celgene revenue rises less than expected due to strong dollarUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)       US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      U.S. biotechnology company Celgene Corp  posted a lower-than-expected quarterly revenue, hit by a stronger dollar, but said the dollar would not hurt full-year sales and profit more that it had already forecast.US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)      US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     * Indexes down: Dow 0.5 pct, S&P; 0.5 pct, Nasdaq 0.9 pct   (Changes comment, updates prices)US STOCKS-Wall St falls on mixed economic data; Apple weighsUS STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)     US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    * Indexes down: Dow 0.6 pct, S&P; 0.6 pct, Nasdaq 1 pct   (Updates to early afternoon)US STOCKS-Wall St drops with tech shares; Nasdaq down for 4th dayCelgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)    Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   * Indexes down: Dow 1.4 pct, S&P; 1.3 pct, Nasdaq 1.9 pct   (Updates to late afternoon)Celgene sales highlight Revlimid dependence ahead of patent rulingCelgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)   Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  April 30 Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.Celgene sales highlight Revlimid dependence ahead of patent rulingUS STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)  US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close) Celgene Corp's dependence on its big-selling multiple myeloma drug Revlimid raised investor concerns on Thursday as sales of its other medicines fell short of expectations.US STOCKS-Wall St drops with tech shares; indexes up for month * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates to close)         
CI,Cigna Q1 revenue rises due to customer additionsCigna sued over mail-order HIV drug programCigna profit beats estimate as it adds more customersCigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors.  Cigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors. Cigna Corp  reported a better-than-expected quarterly profit, helped by an increase in premiums and fees in the health insurer's commercial business, which added more members.Cigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors.   Cigna profit beats estimate as it adds more customersCigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors.  Cigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors. Cigna Corp  reported a better-than-expected quarterly profit, helped by an increase in premiums and fees in the health insurer's commercial business, which added more members.Cigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors.  Cigna Corp has been hit with a lawsuit claiming that the health insurer discriminates against people with HIV/AIDS by forcing them to get some of their medications exclusively from its own mail-order pharmacy as part of a scheme to boost profits.Cigna profit beats estimate as it adds more customersCigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors.  Cigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors. Cigna Corp  reported a better-than-expected quarterly profit, helped by an increase in premiums and fees in the health insurer's commercial business, which added more members.Cigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors.    Cigna sued over mail-order HIV drug programCigna profit beats estimate as it adds more customersCigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors.  Cigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors. Cigna Corp  reported a better-than-expected quarterly profit, helped by an increase in premiums and fees in the health insurer's commercial business, which added more members.Cigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors.   Cigna profit beats estimate as it adds more customersCigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors.  Cigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors. Cigna Corp  reported a better-than-expected quarterly profit, helped by an increase in premiums and fees in the health insurer's commercial business, which added more members.Cigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors.  Cigna Corp has been hit with a lawsuit claiming that the health insurer discriminates against people with HIV/AIDS by forcing them to get some of their medications exclusively from its own mail-order pharmacy as part of a scheme to boost profits.Cigna profit beats estimate as it adds more customersCigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors.  Cigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors. Cigna Corp  reported a better-than-expected quarterly profit, helped by an increase in premiums and fees in the health insurer's commercial business, which added more members.Cigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors.   April 30 U.S. health insurer Cigna Corp  reported an 11.4 percent rise in quarterly revenue, due to an increase in premiums and fees driven by customer additions in its commercial and government businesses.Cigna sued over mail-order HIV drug programCigna profit beats estimate as it adds more customersCigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors.  Cigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors. Cigna Corp  reported a better-than-expected quarterly profit, helped by an increase in premiums and fees in the health insurer's commercial business, which added more members.Cigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors.   Cigna profit beats estimate as it adds more customersCigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors.  Cigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors. Cigna Corp  reported a better-than-expected quarterly profit, helped by an increase in premiums and fees in the health insurer's commercial business, which added more members.Cigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors.  Cigna Corp has been hit with a lawsuit claiming that the health insurer discriminates against people with HIV/AIDS by forcing them to get some of their medications exclusively from its own mail-order pharmacy as part of a scheme to boost profits.Cigna profit beats estimate as it adds more customersCigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors.  Cigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors. Cigna Corp  reported a better-than-expected quarterly profit, helped by an increase in premiums and fees in the health insurer's commercial business, which added more members.Cigna CFO says medical use trends unchanged during first quarter NEW YORK, April 30 Cigna Corp did not experience "any significant change" in the use of medical services during the first quarter, CFO Thomas McCarthy said during a conference call with investors.    
CL,US STOCKS-Futures pare losses on strong jobless claims, consumer spending dataUPDATE 2-Stronger dollar forces Colgate to cut profit forecast againRPT-UPDATE 2-Stronger dollar forces Colgate to cut profit forecast again April 30 Colgate-Palmolive Co cut its profit forecast for the full year again, indicating price rises will not be able to completely offset the impact of a stronger dollar.  RPT-UPDATE 2-Stronger dollar forces Colgate to cut profit forecast again April 30 Colgate-Palmolive Co cut its profit forecast for the full year again, indicating price rises will not be able to completely offset the impact of a stronger dollar.  RPT-UPDATE 2-Stronger dollar forces Colgate to cut profit forecast again April 30 Colgate-Palmolive Co cut its profit forecast for the full year again, indicating price rises will not be able to completely offset the impact of a stronger dollar.   UPDATE 2-Stronger dollar forces Colgate to cut profit forecast againRPT-UPDATE 2-Stronger dollar forces Colgate to cut profit forecast again April 30 Colgate-Palmolive Co cut its profit forecast for the full year again, indicating price rises will not be able to completely offset the impact of a stronger dollar.  RPT-UPDATE 2-Stronger dollar forces Colgate to cut profit forecast again April 30 Colgate-Palmolive Co cut its profit forecast for the full year again, indicating price rises will not be able to completely offset the impact of a stronger dollar.  RPT-UPDATE 2-Stronger dollar forces Colgate to cut profit forecast again April 30 Colgate-Palmolive Co cut its profit forecast for the full year again, indicating price rises will not be able to completely offset the impact of a stronger dollar.  * Futures down: Dow 35 pts, S&P; 4.25 pts, Nasdaq 20.5 pts   (Adds details, comment, updates prices)UPDATE 2-Stronger dollar forces Colgate to cut profit forecast againRPT-UPDATE 2-Stronger dollar forces Colgate to cut profit forecast again April 30 Colgate-Palmolive Co cut its profit forecast for the full year again, indicating price rises will not be able to completely offset the impact of a stronger dollar.  RPT-UPDATE 2-Stronger dollar forces Colgate to cut profit forecast again April 30 Colgate-Palmolive Co cut its profit forecast for the full year again, indicating price rises will not be able to completely offset the impact of a stronger dollar.  RPT-UPDATE 2-Stronger dollar forces Colgate to cut profit forecast again April 30 Colgate-Palmolive Co cut its profit forecast for the full year again, indicating price rises will not be able to completely offset the impact of a stronger dollar.   
COP,ConocoPhillips profit falls sharply on oil pricesUPDATE 2-ConocoPhillips 1st-qtr profit falls sharply on oil price decline April 30 ConocoPhillips, the largest independent U.S. energy company, reported sharply lower quarterly profit on Thursday, hurt by a steep decline in crude oil prices.  UPDATE 2-ConocoPhillips 1st-qtr profit falls sharply on oil price decline April 30 ConocoPhillips, the largest independent U.S. energy company, reported sharply lower quarterly profit on Thursday, hurt by a steep decline in crude oil prices. April 30 ConocoPhillips, the largest independent U.S. energy company, on Thursday reported a sharply lower quarterly profit as results were hurt by a steep decline in crude oil prices.UPDATE 2-ConocoPhillips 1st-qtr profit falls sharply on oil price decline April 30 ConocoPhillips, the largest independent U.S. energy company, reported sharply lower quarterly profit on Thursday, hurt by a steep decline in crude oil prices.  
CCI,Crown Castle to buy Quanta Fiber Networks for 1 blnCrown Castle to buy Quanta Fiber Networks for $1 billion Wireless infrastructure provider Crown Castle International Corp  said it would buy Quanta Fiber Networks Inc for $1 billion to expand its presence in top U.S. metropolitan markets.  Crown Castle to buy Quanta Fiber Networks for $1 billion Wireless infrastructure provider Crown Castle International Corp  said it would buy Quanta Fiber Networks Inc for $1 billion to expand its presence in top U.S. metropolitan markets. April 30 Wireless infrastructure provider Crown Castle International Corp said it would buy Quanta Fiber Networks Inc for $1 billion to expand its presence in top U.S. metropolitan markets.Crown Castle to buy Quanta Fiber Networks for $1 billion Wireless infrastructure provider Crown Castle International Corp  said it would buy Quanta Fiber Networks Inc for $1 billion to expand its presence in top U.S. metropolitan markets.  
CVS,Omnicare draws buyout interest from CVS, Express Scripts - Bloomberg April 30 Pharmacy service provider Omnicare Inc  is getting buyout interest from potential buyers, including Express Scripts Holding Co and CVS Health Corp, Bloomberg reported, citing people with knowledge of the matter. 
DLPH,Delphi Automotive beats quarterly profit expectationsCORRECTED-UPDATE 2-Delphi Automotive CEO-Could spend $3 bln on acquisition in 2015 DETROIT, April 30 Delphi Automotive Plc  Chief Executive Kevin Clark said the company could spend $1 billion to $3 billion this year on a large acquisition related to its traditional "hardware" business and will make smaller investments in software.  CORRECTED-UPDATE 2-Delphi Automotive CEO-Could spend $3 bln on acquisition in 2015 DETROIT, April 30 Delphi Automotive Plc  Chief Executive Kevin Clark said the company could spend $1 billion to $3 billion this year on a large acquisition related to its traditional "hardware" business and will make smaller investments in software. DETROIT, April 30 Auto supplier Delphi Automotive Plc on Thursday posted first quarter profit and revenue results that beat analyst expectations.CORRECTED-UPDATE 2-Delphi Automotive CEO-Could spend $3 bln on acquisition in 2015 DETROIT, April 30 Delphi Automotive Plc  Chief Executive Kevin Clark said the company could spend $1 billion to $3 billion this year on a large acquisition related to its traditional "hardware" business and will make smaller investments in software.  
DOW,Dow Chemical to sell AgroFresh for $860 mln in asset-sale driveDow Chemical to sell AgroFresh for $860 mln in asset-sale drive Dow Chemical Co  said it would sell its AgroFresh unit, which makes chemicals that keep farm produce fresh, for $860 million as part of a plan to divest less-lucrative units.  Dow Chemical to sell AgroFresh for $860 mln in asset-sale drive Dow Chemical Co  said it would sell its AgroFresh unit, which makes chemicals that keep farm produce fresh, for $860 million as part of a plan to divest less-lucrative units. April 30 Dow Chemical Co said it would sell its AgroFresh unit, which makes chemicals that keep farm produce fresh, for $860 million as part of a plan to divest less-lucrative units.Dow Chemical to sell AgroFresh for $860 mln in asset-sale drive Dow Chemical Co  said it would sell its AgroFresh unit, which makes chemicals that keep farm produce fresh, for $860 million as part of a plan to divest less-lucrative units.  
DD,DuPont says Glass Lewis reached "wrong conclusion" in backing Peltz April 30 DuPont said Glass Lewis had reached the "wrong conclusion in failing to recommend a vote" for all 12 of its directors, a day after the proxy advisory firm backed activist investor Nelson Peltz's demand for a board seat. 
DUK,DIARY-U.S. MEETINGS/WEEK AHEAD Thomson Reuters April 30, 2015 - Corporate Meetings for US companies for Week ahead.         S&P; 500 Earnings - MONTH AHEAD     Dividends                            Non S&P; 500 - Weekly             Federal Reserve events               ConferenceCall/Webcast - Weekly  Meetings - Weekly                                Xtra users can see more details on conference calls & webcasts by hovering your mouse  over the RIC, right click, no click on Related Co Data, now click on Co Events.                  
EXPE,Expedia Inc first-quarter profit tops expectationsUPDATE 1-Expedia 1st-qtr profit tops expectationsExpedia Inc maintains 2015 earnings guidance -CFO April 30 Online travel services company Expedia Inc on Thursday affirmed earlier guidance for 2015 earnings but said it expects fierce competition for travel bookings in China to continue to produce quarterly losses for its subsidiary brand eLong Inc.  Expedia Inc maintains 2015 earnings guidance -CFO April 30 Online travel services company Expedia Inc on Thursday affirmed earlier guidance for 2015 earnings but said it expects fierce competition for travel bookings in China to continue to produce quarterly losses for its subsidiary brand eLong Inc. April 30 Expedia Inc on Thursday reported a first-quarter profit that exceeded analysts' expectations as it earned more money from people outside the United States booking travel despite currency fluctuations.Expedia Inc maintains 2015 earnings guidance -CFO April 30 Online travel services company Expedia Inc on Thursday affirmed earlier guidance for 2015 earnings but said it expects fierce competition for travel bookings in China to continue to produce quarterly losses for its subsidiary brand eLong Inc.   UPDATE 1-Expedia 1st-qtr profit tops expectationsExpedia Inc maintains 2015 earnings guidance -CFO April 30 Online travel services company Expedia Inc on Thursday affirmed earlier guidance for 2015 earnings but said it expects fierce competition for travel bookings in China to continue to produce quarterly losses for its subsidiary brand eLong Inc.  Expedia Inc maintains 2015 earnings guidance -CFO April 30 Online travel services company Expedia Inc on Thursday affirmed earlier guidance for 2015 earnings but said it expects fierce competition for travel bookings in China to continue to produce quarterly losses for its subsidiary brand eLong Inc. April 30 Expedia Inc on Thursday reported a first-quarter profit that exceeded analysts' expectations as it earned more money from people outside the United States booking travel despite currency fluctuations.Expedia Inc maintains 2015 earnings guidance -CFO April 30 Online travel services company Expedia Inc on Thursday affirmed earlier guidance for 2015 earnings but said it expects fierce competition for travel bookings in China to continue to produce quarterly losses for its subsidiary brand eLong Inc.  April 30 Expedia Inc on Thursday reported first-quarter profit above analysts' expectations.UPDATE 1-Expedia 1st-qtr profit tops expectationsExpedia Inc maintains 2015 earnings guidance -CFO April 30 Online travel services company Expedia Inc on Thursday affirmed earlier guidance for 2015 earnings but said it expects fierce competition for travel bookings in China to continue to produce quarterly losses for its subsidiary brand eLong Inc.  Expedia Inc maintains 2015 earnings guidance -CFO April 30 Online travel services company Expedia Inc on Thursday affirmed earlier guidance for 2015 earnings but said it expects fierce competition for travel bookings in China to continue to produce quarterly losses for its subsidiary brand eLong Inc. April 30 Expedia Inc on Thursday reported a first-quarter profit that exceeded analysts' expectations as it earned more money from people outside the United States booking travel despite currency fluctuations.Expedia Inc maintains 2015 earnings guidance -CFO April 30 Online travel services company Expedia Inc on Thursday affirmed earlier guidance for 2015 earnings but said it expects fierce competition for travel bookings in China to continue to produce quarterly losses for its subsidiary brand eLong Inc.   
ESRX,Omnicare draws buyout interest from CVS, Express Scripts - Bloomberg April 30 Pharmacy service provider Omnicare Inc  is getting buyout interest from potential buyers, including Express Scripts Holding Co and CVS Health Corp, Bloomberg reported, citing people with knowledge of the matter. 
XOM,Exxon quarterly profit falls 46 percentBRIEF-Exxon exec says has just under 40 U.S. shale rigs runningUPDATE 3-Exxon profit slips but beats forecasts on refining, output April 30 Exxon Mobil Corp's  first-quarter profit dropped less than expected in results posted on Thursday as margins at the refining unit of the world's largest publicly traded oil company surged on tumbling crude prices.  UPDATE 3-Exxon profit slips but beats forecasts on refining, output April 30 Exxon Mobil Corp's  first-quarter profit dropped less than expected in results posted on Thursday as margins at the refining unit of the world's largest publicly traded oil company surged on tumbling crude prices. * Exec says the company has the financial strength for potential acquisition targetsUPDATE 3-Exxon profit slips but beats forecasts on refining, output April 30 Exxon Mobil Corp's  first-quarter profit dropped less than expected in results posted on Thursday as margins at the refining unit of the world's largest publicly traded oil company surged on tumbling crude prices.   BRIEF-Exxon exec says has just under 40 U.S. shale rigs runningUPDATE 3-Exxon profit slips but beats forecasts on refining, output April 30 Exxon Mobil Corp's  first-quarter profit dropped less than expected in results posted on Thursday as margins at the refining unit of the world's largest publicly traded oil company surged on tumbling crude prices.  UPDATE 3-Exxon profit slips but beats forecasts on refining, output April 30 Exxon Mobil Corp's  first-quarter profit dropped less than expected in results posted on Thursday as margins at the refining unit of the world's largest publicly traded oil company surged on tumbling crude prices. * Exec says the company has the financial strength for potential acquisition targetsUPDATE 3-Exxon profit slips but beats forecasts on refining, output April 30 Exxon Mobil Corp's  first-quarter profit dropped less than expected in results posted on Thursday as margins at the refining unit of the world's largest publicly traded oil company surged on tumbling crude prices.  April 30 Exxon Mobil Corp on Thursday reported a 46 percent decline in quarterly earnings as a steep drop in crude prices cut into profits at the world's largest publicly traded oil company.BRIEF-Exxon exec says has just under 40 U.S. shale rigs runningUPDATE 3-Exxon profit slips but beats forecasts on refining, output April 30 Exxon Mobil Corp's  first-quarter profit dropped less than expected in results posted on Thursday as margins at the refining unit of the world's largest publicly traded oil company surged on tumbling crude prices.  UPDATE 3-Exxon profit slips but beats forecasts on refining, output April 30 Exxon Mobil Corp's  first-quarter profit dropped less than expected in results posted on Thursday as margins at the refining unit of the world's largest publicly traded oil company surged on tumbling crude prices. * Exec says the company has the financial strength for potential acquisition targetsUPDATE 3-Exxon profit slips but beats forecasts on refining, output April 30 Exxon Mobil Corp's  first-quarter profit dropped less than expected in results posted on Thursday as margins at the refining unit of the world's largest publicly traded oil company surged on tumbling crude prices.   
FSLR,Solar panel maker First Solar reports quarterly lossSolar panel maker First Solar reports quarterly lossUPDATE 1-SunPower, First Solar post loss ahead of spinoff of some plants April 30 Solar panel makers SunPower Corp  and First Solar Inc reported a quarterly loss, compared with a year-earlier profit, as they sold fewer power plants ahead of a spinoff of some of their assets into a joint public entity.  UPDATE 1-SunPower, First Solar post loss ahead of spinoff of some plants April 30 Solar panel makers SunPower Corp  and First Solar Inc reported a quarterly loss, compared with a year-earlier profit, as they sold fewer power plants ahead of a spinoff of some of their assets into a joint public entity. U.S. solar panel maker First Solar Inc  reported a quarterly loss, compared with a year-earlier profit, as it sold fewer power plants.UPDATE 1-SunPower, First Solar post loss ahead of spinoff of some plants April 30 Solar panel makers SunPower Corp  and First Solar Inc reported a quarterly loss, compared with a year-earlier profit, as they sold fewer power plants ahead of a spinoff of some of their assets into a joint public entity.   Solar panel maker First Solar reports quarterly lossUPDATE 1-SunPower, First Solar post loss ahead of spinoff of some plants April 30 Solar panel makers SunPower Corp  and First Solar Inc reported a quarterly loss, compared with a year-earlier profit, as they sold fewer power plants ahead of a spinoff of some of their assets into a joint public entity.  UPDATE 1-SunPower, First Solar post loss ahead of spinoff of some plants April 30 Solar panel makers SunPower Corp  and First Solar Inc reported a quarterly loss, compared with a year-earlier profit, as they sold fewer power plants ahead of a spinoff of some of their assets into a joint public entity. U.S. solar panel maker First Solar Inc  reported a quarterly loss, compared with a year-earlier profit, as it sold fewer power plants.UPDATE 1-SunPower, First Solar post loss ahead of spinoff of some plants April 30 Solar panel makers SunPower Corp  and First Solar Inc reported a quarterly loss, compared with a year-earlier profit, as they sold fewer power plants ahead of a spinoff of some of their assets into a joint public entity.  April 30 U.S. solar panel maker First Solar Inc  reported a quarterly loss, compared with a year-earlier profit, as it sold fewer power plants.Solar panel maker First Solar reports quarterly lossUPDATE 1-SunPower, First Solar post loss ahead of spinoff of some plants April 30 Solar panel makers SunPower Corp  and First Solar Inc reported a quarterly loss, compared with a year-earlier profit, as they sold fewer power plants ahead of a spinoff of some of their assets into a joint public entity.  UPDATE 1-SunPower, First Solar post loss ahead of spinoff of some plants April 30 Solar panel makers SunPower Corp  and First Solar Inc reported a quarterly loss, compared with a year-earlier profit, as they sold fewer power plants ahead of a spinoff of some of their assets into a joint public entity. U.S. solar panel maker First Solar Inc  reported a quarterly loss, compared with a year-earlier profit, as it sold fewer power plants.UPDATE 1-SunPower, First Solar post loss ahead of spinoff of some plants April 30 Solar panel makers SunPower Corp  and First Solar Inc reported a quarterly loss, compared with a year-earlier profit, as they sold fewer power plants ahead of a spinoff of some of their assets into a joint public entity.   
F,Ford CEO Fields not looking at consolidation moves - CNBC April 30 Ford Motor Co Chief Executive Officer Mark Fields told CNBC on Thursday the No. 2 U.S. automaker is not looking at a consolidation move with another company. 
GM,GM to invest $5.4 bln in U.S. plants over next 3 yearsUPDATE 1-GM to invest $5.4 bln in U.S. plants over next 3 yearsGM to invest $5.4 billion in U.S. plants over next three years DETROIT General Motors Co  said on Thursday it will spend $5.4 billion over the next three years on its U.S. manufacturing plants to boost production and vehicle quality.  GM to invest $5.4 billion in U.S. plants over next three years DETROIT General Motors Co  said on Thursday it will spend $5.4 billion over the next three years on its U.S. manufacturing plants to boost production and vehicle quality. DETROIT, April 30 General Motors Co said on Thursday it will spend $5.4 billion over the next three years on its U.S. manufacturing plants to boost production and vehicle quality.GM to invest $5.4 billion in U.S. plants over next three years DETROIT General Motors Co  said on Thursday it will spend $5.4 billion over the next three years on its U.S. manufacturing plants to boost production and vehicle quality.   UPDATE 1-GM to invest $5.4 bln in U.S. plants over next 3 yearsGM to invest $5.4 billion in U.S. plants over next three years DETROIT General Motors Co  said on Thursday it will spend $5.4 billion over the next three years on its U.S. manufacturing plants to boost production and vehicle quality.  GM to invest $5.4 billion in U.S. plants over next three years DETROIT General Motors Co  said on Thursday it will spend $5.4 billion over the next three years on its U.S. manufacturing plants to boost production and vehicle quality. DETROIT, April 30 General Motors Co said on Thursday it will spend $5.4 billion over the next three years on its U.S. manufacturing plants to boost production and vehicle quality.GM to invest $5.4 billion in U.S. plants over next three years DETROIT General Motors Co  said on Thursday it will spend $5.4 billion over the next three years on its U.S. manufacturing plants to boost production and vehicle quality.  DETROIT, April 30 General Motors Co on Thursday said it will spend $5.4 billion over the next three years on its U.S. manufacturing plants to boost production and vehicle quality.UPDATE 1-GM to invest $5.4 bln in U.S. plants over next 3 yearsGM to invest $5.4 billion in U.S. plants over next three years DETROIT General Motors Co  said on Thursday it will spend $5.4 billion over the next three years on its U.S. manufacturing plants to boost production and vehicle quality.  GM to invest $5.4 billion in U.S. plants over next three years DETROIT General Motors Co  said on Thursday it will spend $5.4 billion over the next three years on its U.S. manufacturing plants to boost production and vehicle quality. DETROIT, April 30 General Motors Co said on Thursday it will spend $5.4 billion over the next three years on its U.S. manufacturing plants to boost production and vehicle quality.GM to invest $5.4 billion in U.S. plants over next three years DETROIT General Motors Co  said on Thursday it will spend $5.4 billion over the next three years on its U.S. manufacturing plants to boost production and vehicle quality.   
GILD,Gilead 1st-qtr profit doubles on strong hepatitis C drug salesUS STOCKS-Wall St drops with tech shares; LinkedIn falls lateUPDATE 2-Gilead first-quarter profit doubles on strong hepatitis C drug sales LOS ANGELES, April 30 Gilead Sciences Inc  on Thursday said its quarterly profit nearly doubled, driven by strong sales of its hepatitis C drugs, as it topped Wall Street estimates.  UPDATE 2-Gilead first-quarter profit doubles on strong hepatitis C drug sales LOS ANGELES, April 30 Gilead Sciences Inc  on Thursday said its quarterly profit nearly doubled, driven by strong sales of its hepatitis C drugs, as it topped Wall Street estimates. * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)UPDATE 2-Gilead first-quarter profit doubles on strong hepatitis C drug sales LOS ANGELES, April 30 Gilead Sciences Inc  on Thursday said its quarterly profit nearly doubled, driven by strong sales of its hepatitis C drugs, as it topped Wall Street estimates.   US STOCKS-Wall St drops with tech shares; LinkedIn falls lateUPDATE 2-Gilead first-quarter profit doubles on strong hepatitis C drug sales LOS ANGELES, April 30 Gilead Sciences Inc  on Thursday said its quarterly profit nearly doubled, driven by strong sales of its hepatitis C drugs, as it topped Wall Street estimates.  UPDATE 2-Gilead first-quarter profit doubles on strong hepatitis C drug sales LOS ANGELES, April 30 Gilead Sciences Inc  on Thursday said its quarterly profit nearly doubled, driven by strong sales of its hepatitis C drugs, as it topped Wall Street estimates. * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)UPDATE 2-Gilead first-quarter profit doubles on strong hepatitis C drug sales LOS ANGELES, April 30 Gilead Sciences Inc  on Thursday said its quarterly profit nearly doubled, driven by strong sales of its hepatitis C drugs, as it topped Wall Street estimates.  April 30 Gilead Sciences Inc said on Thursday its quarterly net profit nearly doubled, driven by sales of its novel hepatitis C drugs, as it topped Wall Street estimates.US STOCKS-Wall St drops with tech shares; LinkedIn falls lateUPDATE 2-Gilead first-quarter profit doubles on strong hepatitis C drug sales LOS ANGELES, April 30 Gilead Sciences Inc  on Thursday said its quarterly profit nearly doubled, driven by strong sales of its hepatitis C drugs, as it topped Wall Street estimates.  UPDATE 2-Gilead first-quarter profit doubles on strong hepatitis C drug sales LOS ANGELES, April 30 Gilead Sciences Inc  on Thursday said its quarterly profit nearly doubled, driven by strong sales of its hepatitis C drugs, as it topped Wall Street estimates. * Indexes down: Dow 1.1 pct, S&P; 1 pct, Nasdaq 1.6 pct   (Updates close with LinkedIn, solar company shares down after the bell, Gilead up, small caps down, new quote)UPDATE 2-Gilead first-quarter profit doubles on strong hepatitis C drug sales LOS ANGELES, April 30 Gilead Sciences Inc  on Thursday said its quarterly profit nearly doubled, driven by strong sales of its hepatitis C drugs, as it topped Wall Street estimates.   
HAR,Harman revenue rises on strong demand for car audio products April 30 Harman International Industries Inc , the maker of JBL and Harman Kardon audio systems, reported a 4 percent rise in quarterly revenue as strong U.S. auto sales boosted demand for the company's car infotainment products. 
MPC,Marathon Petroleum says to split stock as refining profit surges HOUSTON, April 30 Marathon Petroleum Corp. , the fourth-largest U.S. refiner, said on Thursday it would split its stock 2-for-1 in June as cheap domestic crude oils allow refiners to book healthy profits for fuels they make. 
MCD,CORRECTED-OSI cuts 340 workers from embattled Shanghai plant, shutdown loomsOSI cuts 340 workers from embattled Shanghai plant, shutdown loomsUPDATE 1-McDonald's fries supplier fined in China for water pollution SHANGHAI, April 30 Beijing authorities have fined U.S.-based J.R. Simplot's China processing unit, which supplies frozen french fries to McDonald's Corp, 3.92 million yuan ($632,370) for water pollution, state media and Simplot said.  UPDATE 1-McDonald's fries supplier fined in China for water pollution SHANGHAI, April 30 Beijing authorities have fined U.S.-based J.R. Simplot's China processing unit, which supplies frozen french fries to McDonald's Corp, 3.92 million yuan ($632,370) for water pollution, state media and Simplot said. SHANGHAI U.S. food firm OSI Group LLC [OSIGP.UL] has cut 340 jobs at its embattled Shanghai plant, which supplied McDonald's Corp and Yum Brands Inc, bringing the facility close to shutdown, the firm said in a statement on its website on Monday.UPDATE 1-McDonald's fries supplier fined in China for water pollution SHANGHAI, April 30 Beijing authorities have fined U.S.-based J.R. Simplot's China processing unit, which supplies frozen french fries to McDonald's Corp, 3.92 million yuan ($632,370) for water pollution, state media and Simplot said.   OSI cuts 340 workers from embattled Shanghai plant, shutdown loomsUPDATE 1-McDonald's fries supplier fined in China for water pollution SHANGHAI, April 30 Beijing authorities have fined U.S.-based J.R. Simplot's China processing unit, which supplies frozen french fries to McDonald's Corp, 3.92 million yuan ($632,370) for water pollution, state media and Simplot said.  UPDATE 1-McDonald's fries supplier fined in China for water pollution SHANGHAI, April 30 Beijing authorities have fined U.S.-based J.R. Simplot's China processing unit, which supplies frozen french fries to McDonald's Corp, 3.92 million yuan ($632,370) for water pollution, state media and Simplot said. SHANGHAI U.S. food firm OSI Group LLC [OSIGP.UL] has cut 340 jobs at its embattled Shanghai plant, which supplied McDonald's Corp and Yum Brands Inc, bringing the facility close to shutdown, the firm said in a statement on its website on Monday.UPDATE 1-McDonald's fries supplier fined in China for water pollution SHANGHAI, April 30 Beijing authorities have fined U.S.-based J.R. Simplot's China processing unit, which supplies frozen french fries to McDonald's Corp, 3.92 million yuan ($632,370) for water pollution, state media and Simplot said.  SHANGHAI, Sept 22 U.S. food firm OSI Group LLC  has cut 340 jobs at its embattled Shanghai plant, which supplied McDonald's Corp and Yum Brands Inc , bringing the facility close to shutdown, the firm said in a statement on its website on Monday.OSI cuts 340 workers from embattled Shanghai plant, shutdown loomsUPDATE 1-McDonald's fries supplier fined in China for water pollution SHANGHAI, April 30 Beijing authorities have fined U.S.-based J.R. Simplot's China processing unit, which supplies frozen french fries to McDonald's Corp, 3.92 million yuan ($632,370) for water pollution, state media and Simplot said.  UPDATE 1-McDonald's fries supplier fined in China for water pollution SHANGHAI, April 30 Beijing authorities have fined U.S.-based J.R. Simplot's China processing unit, which supplies frozen french fries to McDonald's Corp, 3.92 million yuan ($632,370) for water pollution, state media and Simplot said. SHANGHAI U.S. food firm OSI Group LLC [OSIGP.UL] has cut 340 jobs at its embattled Shanghai plant, which supplied McDonald's Corp and Yum Brands Inc, bringing the facility close to shutdown, the firm said in a statement on its website on Monday.UPDATE 1-McDonald's fries supplier fined in China for water pollution SHANGHAI, April 30 Beijing authorities have fined U.S.-based J.R. Simplot's China processing unit, which supplies frozen french fries to McDonald's Corp, 3.92 million yuan ($632,370) for water pollution, state media and Simplot said.   
MCK,Omnicare draws buyout interest from CVS, Express Scripts - BloombergOmnicare draws buyout interest from CVS, Express Scripts: BloombergMcKesson settles investigation on controlled substances April 30 U.S. drug wholesaler McKesson Corp  said it settled with several federal agencies, including the Department of Justice, claims alleging suspicious order reporting practices for controlled substances.  McKesson settles investigation on controlled substances April 30 U.S. drug wholesaler McKesson Corp  said it settled with several federal agencies, including the Department of Justice, claims alleging suspicious order reporting practices for controlled substances. Pharmacy service provider Omnicare Inc  is getting buyout interest from potential buyers, including Express Scripts Holding Co  and CVS Health Corp , Bloomberg reported, citing people with knowledge of the matter.McKesson settles investigation on controlled substances April 30 U.S. drug wholesaler McKesson Corp  said it settled with several federal agencies, including the Department of Justice, claims alleging suspicious order reporting practices for controlled substances.   Omnicare draws buyout interest from CVS, Express Scripts: BloombergMcKesson settles investigation on controlled substances April 30 U.S. drug wholesaler McKesson Corp  said it settled with several federal agencies, including the Department of Justice, claims alleging suspicious order reporting practices for controlled substances.  McKesson settles investigation on controlled substances April 30 U.S. drug wholesaler McKesson Corp  said it settled with several federal agencies, including the Department of Justice, claims alleging suspicious order reporting practices for controlled substances. Pharmacy service provider Omnicare Inc  is getting buyout interest from potential buyers, including Express Scripts Holding Co  and CVS Health Corp , Bloomberg reported, citing people with knowledge of the matter.McKesson settles investigation on controlled substances April 30 U.S. drug wholesaler McKesson Corp  said it settled with several federal agencies, including the Department of Justice, claims alleging suspicious order reporting practices for controlled substances.  April 30 Pharmacy service provider Omnicare Inc  is getting buyout interest from potential buyers, including Express Scripts Holding Co and CVS Health Corp, Bloomberg reported, citing people with knowledge of the matter.Omnicare draws buyout interest from CVS, Express Scripts: BloombergMcKesson settles investigation on controlled substances April 30 U.S. drug wholesaler McKesson Corp  said it settled with several federal agencies, including the Department of Justice, claims alleging suspicious order reporting practices for controlled substances.  McKesson settles investigation on controlled substances April 30 U.S. drug wholesaler McKesson Corp  said it settled with several federal agencies, including the Department of Justice, claims alleging suspicious order reporting practices for controlled substances. Pharmacy service provider Omnicare Inc  is getting buyout interest from potential buyers, including Express Scripts Holding Co  and CVS Health Corp , Bloomberg reported, citing people with knowledge of the matter.McKesson settles investigation on controlled substances April 30 U.S. drug wholesaler McKesson Corp  said it settled with several federal agencies, including the Department of Justice, claims alleging suspicious order reporting practices for controlled substances.   
MSFT,Microsoft opens door to Android, Apple phone appsUPDATE 2-Oracle CEO sees benefit if rival buys Salesforce.com REDWOOD CITY, Calif., April 30 Oracle Corp  Chief Executive Safra Catz said her company could benefit if Microsoft Corp or another rival bought online customer relationship management firm Salesforce.com Inc .  UPDATE 2-Oracle CEO sees benefit if rival buys Salesforce.com REDWOOD CITY, Calif., April 30 Oracle Corp  Chief Executive Safra Catz said her company could benefit if Microsoft Corp or another rival bought online customer relationship management firm Salesforce.com Inc . SAN FRANCISCO Microsoft Corp  is making it easier for apps written for rival Google Inc's  Android and Apple Inc's  iOS systems to work on Windows phones, in a bid to attract users to its unpopular mobile devices, the company's operating systems chief said on Wednesday.UPDATE 2-Oracle CEO sees benefit if rival buys Salesforce.com REDWOOD CITY, Calif., April 30 Oracle Corp  Chief Executive Safra Catz said her company could benefit if Microsoft Corp or another rival bought online customer relationship management firm Salesforce.com Inc .  
MON,Monsanto offers to buy Syngenta again -Bloomberg April 30 Monsanto, the world's largest seed company has again approached Switzerland's Syngenta  in recent weeks with an offer to buy the company, Bloomberg reported citing people familiar with the matter. 
MYL,BRIEF-Teva CEO on Mylan bidUPDATE 2-Teva lifts 2015 earnings forecast as pursues Mylan bidTeva lifts 2015 earnings forecast as pursues Mylan bid TEL AVIV Teva Pharmaceutical Industries  raised its 2015 earnings forecast after beating first-quarter estimates, and said it would devote "all necessary resources" to its $40 billion-plus bid for rival Mylan Inc .  Teva lifts 2015 earnings forecast as pursues Mylan bid TEL AVIV Teva Pharmaceutical Industries  raised its 2015 earnings forecast after beating first-quarter estimates, and said it would devote "all necessary resources" to its $40 billion-plus bid for rival Mylan Inc . * Teva shares down 1.2 pct in New York   (Adds comments on Mylan, Copaxone, analyst, shares)Teva lifts 2015 earnings forecast as pursues Mylan bid TEL AVIV Teva Pharmaceutical Industries  raised its 2015 earnings forecast after beating first-quarter estimates, and said it would devote "all necessary resources" to its $40 billion-plus bid for rival Mylan Inc .   UPDATE 2-Teva lifts 2015 earnings forecast as pursues Mylan bidTeva lifts 2015 earnings forecast as pursues Mylan bid TEL AVIV Teva Pharmaceutical Industries  raised its 2015 earnings forecast after beating first-quarter estimates, and said it would devote "all necessary resources" to its $40 billion-plus bid for rival Mylan Inc .  Teva lifts 2015 earnings forecast as pursues Mylan bid TEL AVIV Teva Pharmaceutical Industries  raised its 2015 earnings forecast after beating first-quarter estimates, and said it would devote "all necessary resources" to its $40 billion-plus bid for rival Mylan Inc . * Teva shares down 1.2 pct in New York   (Adds comments on Mylan, Copaxone, analyst, shares)Teva lifts 2015 earnings forecast as pursues Mylan bid TEL AVIV Teva Pharmaceutical Industries  raised its 2015 earnings forecast after beating first-quarter estimates, and said it would devote "all necessary resources" to its $40 billion-plus bid for rival Mylan Inc .  April 30 Teva Pharmaceutical Industries  TEVA.N> CEO Erez Vigodman says:UPDATE 2-Teva lifts 2015 earnings forecast as pursues Mylan bidTeva lifts 2015 earnings forecast as pursues Mylan bid TEL AVIV Teva Pharmaceutical Industries  raised its 2015 earnings forecast after beating first-quarter estimates, and said it would devote "all necessary resources" to its $40 billion-plus bid for rival Mylan Inc .  Teva lifts 2015 earnings forecast as pursues Mylan bid TEL AVIV Teva Pharmaceutical Industries  raised its 2015 earnings forecast after beating first-quarter estimates, and said it would devote "all necessary resources" to its $40 billion-plus bid for rival Mylan Inc . * Teva shares down 1.2 pct in New York   (Adds comments on Mylan, Copaxone, analyst, shares)Teva lifts 2015 earnings forecast as pursues Mylan bid TEL AVIV Teva Pharmaceutical Industries  raised its 2015 earnings forecast after beating first-quarter estimates, and said it would devote "all necessary resources" to its $40 billion-plus bid for rival Mylan Inc .   
NEM,UPDATE 2-Newmont agrees to sell New Zealand gold mine to OceanaGold April 29 Newmont Mining Corp said on Wednesday it has tentatively agreed to sell its Waihi gold mining operation in New Zealand to OceanaGold Corp for about $106 million plus a 1 percent net smelter royalty on a recent discovery near the mine. 
NKE,CORRECTED-Obama to push case for trade deal at Nike headquarters in Oregon WASHINGTON, April 30 President Barack Obama will travel to Nike Inc headquarters in Oregon next Friday to argue that a 12-nation Pacific trade deal and the fast-track legislation needed to finalize the pact are good for workers. 
ORCL,Oracle CEO Safra Catz declines comment on Salesforce.comUPDATE 2-Oracle CEO sees benefit if rival buys Salesforce.com REDWOOD CITY, Calif., April 30 Oracle Corp  Chief Executive Safra Catz said her company could benefit if Microsoft Corp or another rival bought online customer relationship management firm Salesforce.com Inc .  UPDATE 2-Oracle CEO sees benefit if rival buys Salesforce.com REDWOOD CITY, Calif., April 30 Oracle Corp  Chief Executive Safra Catz said her company could benefit if Microsoft Corp or another rival bought online customer relationship management firm Salesforce.com Inc . REDWOOD CITY, Calif., April 30 Oracle Corp  Chief Executive Safra Catz on Thursday declined comment on whether Oracle had made an offer to buy online customer relationship management rival Salesforce.com Inc.UPDATE 2-Oracle CEO sees benefit if rival buys Salesforce.com REDWOOD CITY, Calif., April 30 Oracle Corp  Chief Executive Safra Catz said her company could benefit if Microsoft Corp or another rival bought online customer relationship management firm Salesforce.com Inc .  
PKI,PerkinElmer profit tops Street forecast; lowers full-year view April 30 Scientific instruments maker PerkinElmer Inc on Thursday reported higher-than-expected first quarter profit despite the impact of the strong dollar on overseas sales that led the company to lower its full-year earnings forecast. 
CRM,Oracle CEO Safra Catz declines comment on Salesforce.comUPDATE 2-Oracle CEO sees benefit if rival buys Salesforce.com REDWOOD CITY, Calif., April 30 Oracle Corp  Chief Executive Safra Catz said her company could benefit if Microsoft Corp or another rival bought online customer relationship management firm Salesforce.com Inc .  UPDATE 2-Oracle CEO sees benefit if rival buys Salesforce.com REDWOOD CITY, Calif., April 30 Oracle Corp  Chief Executive Safra Catz said her company could benefit if Microsoft Corp or another rival bought online customer relationship management firm Salesforce.com Inc . REDWOOD CITY, Calif., April 30 Oracle Corp  Chief Executive Safra Catz on Thursday declined comment on whether Oracle had made an offer to buy online customer relationship management rival Salesforce.com Inc.UPDATE 2-Oracle CEO sees benefit if rival buys Salesforce.com REDWOOD CITY, Calif., April 30 Oracle Corp  Chief Executive Safra Catz said her company could benefit if Microsoft Corp or another rival bought online customer relationship management firm Salesforce.com Inc .  
SLB,Russia's Eurasia Drilling extends deadline on Schlumberger deal MOSCOW, April 30 Russia's Eurasia Drilling  said on Thursday it had  agreed to extend a deadline on a proposed deal to sell a stake to international oilfield services firm Schlumberger from to April 30 to May 31. 
MOS,Mosaic posts 36 pct rise in quarterly profitPotash Corp sees lower-than-expected prices hurting profit Potash Corp of Saskatchewan's   quarterly profit missed estimates and the company cut its full-year profit forecast, citing lower-than-expected potash prices.  Potash Corp sees lower-than-expected prices hurting profit Potash Corp of Saskatchewan's   quarterly profit missed estimates and the company cut its full-year profit forecast, citing lower-than-expected potash prices. April 30 U.S. fertilizer company Mosaic Co  reported an about 36 percent rise in quarterly profit, helped by lower costs and higher phosphate and potash prices.Potash Corp sees lower-than-expected prices hurting profit Potash Corp of Saskatchewan's   quarterly profit missed estimates and the company cut its full-year profit forecast, citing lower-than-expected potash prices.  
VLO,DIARY-U.S. MEETINGS/WEEK AHEADValero CEO sees growth, but not acquisitions SAN ANTONIO, April 30 Valero Energy Corp  is taking advantage of low oil prices to aggressively build out its refining and logistical assets, but new acquisitions are not planned, Chief Executive Joe Gorder said at the company's annual shareholders meeting on Thursday.  Valero CEO sees growth, but not acquisitions SAN ANTONIO, April 30 Valero Energy Corp  is taking advantage of low oil prices to aggressively build out its refining and logistical assets, but new acquisitions are not planned, Chief Executive Joe Gorder said at the company's annual shareholders meeting on Thursday. Thomson Reuters April 30, 2015 - Corporate Meetings for US companies for Week ahead.         S&P; 500 Earnings - MONTH AHEAD     Dividends                            Non S&P; 500 - Weekly             Federal Reserve events               ConferenceCall/Webcast - Weekly  Meetings - Weekly                                Xtra users can see more details on conference calls & webcasts by hovering your mouse  over the RIC, right click, no click on Related Co Data, now click on Co Events.                 Valero CEO sees growth, but not acquisitions SAN ANTONIO, April 30 Valero Energy Corp  is taking advantage of low oil prices to aggressively build out its refining and logistical assets, but new acquisitions are not planned, Chief Executive Joe Gorder said at the company's annual shareholders meeting on Thursday.  
V,Visa quarterly operating revenue rises 7.8 pctUPDATE 2-Visa forecasts current-quarter profit below Street April 30 Visa Inc, the world's largest credit and debit card company, forecast profit below Wall Street expectations for the current quarter, hurt by continued pressure from lower crude prices and a strong dollar.  UPDATE 2-Visa forecasts current-quarter profit below Street April 30 Visa Inc, the world's largest credit and debit card company, forecast profit below Wall Street expectations for the current quarter, hurt by continued pressure from lower crude prices and a strong dollar. April 30 Visa Inc, the world's largest credit and debit card company, reported a 7.8 percent rise in second-quarter operating revenue as more customers used cards for payments.UPDATE 2-Visa forecasts current-quarter profit below Street April 30 Visa Inc, the world's largest credit and debit card company, forecast profit below Wall Street expectations for the current quarter, hurt by continued pressure from lower crude prices and a strong dollar.  
WU,Western Union's revenue falls as it earns lower feesUPDATE 2-Western Union expects pricing at "low single-digit range" * Revenue from digital business rises 17 pct   (Adds details from conference call, CFO comment)  UPDATE 2-Western Union expects pricing at "low single-digit range" * Revenue from digital business rises 17 pct   (Adds details from conference call, CFO comment) April 30 Western Union Co reported a 2 percent fall in quarterly revenue as it earned lower fees from its money-transfer services.UPDATE 2-Western Union expects pricing at "low single-digit range" * Revenue from digital business rises 17 pct   (Adds details from conference call, CFO comment)  
YUM,CORRECTED-JV of McDonald's fries supplier fined in China for water pollution - XinhuaCORRECTED-OSI cuts 340 workers from embattled Shanghai plant, shutdown loomsUPDATE 1-McDonald's fries supplier fined in China for water pollution SHANGHAI, April 30 Beijing authorities have fined U.S.-based J.R. Simplot's China processing unit, which supplies frozen french fries to McDonald's Corp, 3.92 million yuan ($632,370) for water pollution, state media and Simplot said.  UPDATE 1-McDonald's fries supplier fined in China for water pollution SHANGHAI, April 30 Beijing authorities have fined U.S.-based J.R. Simplot's China processing unit, which supplies frozen french fries to McDonald's Corp, 3.92 million yuan ($632,370) for water pollution, state media and Simplot said. SHANGHAI, Sept 22 U.S. food firm OSI Group LLC  has cut 340 jobs at its embattled Shanghai plant, which supplied McDonald's Corp and Yum Brands Inc , bringing the facility close to shutdown, the firm said in a statement on its website on Monday.UPDATE 1-McDonald's fries supplier fined in China for water pollution SHANGHAI, April 30 Beijing authorities have fined U.S.-based J.R. Simplot's China processing unit, which supplies frozen french fries to McDonald's Corp, 3.92 million yuan ($632,370) for water pollution, state media and Simplot said.   CORRECTED-OSI cuts 340 workers from embattled Shanghai plant, shutdown loomsUPDATE 1-McDonald's fries supplier fined in China for water pollution SHANGHAI, April 30 Beijing authorities have fined U.S.-based J.R. Simplot's China processing unit, which supplies frozen french fries to McDonald's Corp, 3.92 million yuan ($632,370) for water pollution, state media and Simplot said.  UPDATE 1-McDonald's fries supplier fined in China for water pollution SHANGHAI, April 30 Beijing authorities have fined U.S.-based J.R. Simplot's China processing unit, which supplies frozen french fries to McDonald's Corp, 3.92 million yuan ($632,370) for water pollution, state media and Simplot said. SHANGHAI, Sept 22 U.S. food firm OSI Group LLC  has cut 340 jobs at its embattled Shanghai plant, which supplied McDonald's Corp and Yum Brands Inc , bringing the facility close to shutdown, the firm said in a statement on its website on Monday.UPDATE 1-McDonald's fries supplier fined in China for water pollution SHANGHAI, April 30 Beijing authorities have fined U.S.-based J.R. Simplot's China processing unit, which supplies frozen french fries to McDonald's Corp, 3.92 million yuan ($632,370) for water pollution, state media and Simplot said.  SHANGHAI, April 29 A Chinese joint venture of U.S.-based J.R. Simplot, which supplies frozen french fries to McDonald's Corp, was fined 3.92 million yuan ($632,370) on Wednesday by the Beijing city government for water pollution, the official Xinhua news agency reported.CORRECTED-OSI cuts 340 workers from embattled Shanghai plant, shutdown loomsUPDATE 1-McDonald's fries supplier fined in China for water pollution SHANGHAI, April 30 Beijing authorities have fined U.S.-based J.R. Simplot's China processing unit, which supplies frozen french fries to McDonald's Corp, 3.92 million yuan ($632,370) for water pollution, state media and Simplot said.  UPDATE 1-McDonald's fries supplier fined in China for water pollution SHANGHAI, April 30 Beijing authorities have fined U.S.-based J.R. Simplot's China processing unit, which supplies frozen french fries to McDonald's Corp, 3.92 million yuan ($632,370) for water pollution, state media and Simplot said. SHANGHAI, Sept 22 U.S. food firm OSI Group LLC  has cut 340 jobs at its embattled Shanghai plant, which supplied McDonald's Corp and Yum Brands Inc , bringing the facility close to shutdown, the firm said in a statement on its website on Monday.UPDATE 1-McDonald's fries supplier fined in China for water pollution SHANGHAI, April 30 Beijing authorities have fined U.S.-based J.R. Simplot's China processing unit, which supplies frozen french fries to McDonald's Corp, 3.92 million yuan ($632,370) for water pollution, state media and Simplot said.   
